Annovis Bio, Inc. (ANVS) Stock Skyrockets Following Success of Clinical Trial and Subsequent Public Offering
Annovis Bio, Inc. (ANVS) stock prices skyrocketed by a staggering 127.27% as of the market closing on May 21st, 2021, bringing the price per share up to an even USD$60.00. ANVS401 Study The company announced on May 21st, 2021 the success of its double-blind placebo-controlled study in the treatment of Alzheimer’s Disease. Patients treated with […]
